Habeeb Majeed
Toronto, ON M4N3M5, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
The Real-World Experience of the Biosimilar (Grastofil®) to the Reference Biologic (Neupogen®) in Breast Cancer and Lymphoma: A Canadian Single-Centre Retrospective Study.
Journal: Current oncology (Toronto, Ont.)
Published: January 07, 2022
A retrospective review of the real-world experience of the Pegfilgrastim biosimilar (Lapelga®) to the reference biologic (Neulasta®).
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: November 20, 2020
Cost-effectiveness of docetaxel in high-volume hormone-sensitive metastatic prostate cancer.
Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: May 01, 2019
Primary Febrile Neutropenia Prophylaxis for Patients Who Receive FEC-D Chemotherapy for Breast Cancer: A Systematic Review.
Journal: Journal of global oncology
Published: September 23, 2018
Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2.
Journal: Cancer immunology, immunotherapy : CII
Published: June 07, 2018
Personalized medicine in immuno-oncology: a novel prognostic index in non-small cell lung cancer.
Journal: Journal of thoracic disease
Published: June 01, 2018
Absolute benefit from adjuvant chemotherapy in contemporary clinical trials: A systemic review and meta-analysis.
Journal: Cancer treatment reviews
Published: April 25, 2018
EQUATOR-Oncology: reducing the latitude of cancer trial design and reporting.
Journal: British journal of cancer
Published: February 23, 2018
Acute Kidney Injury in Patients Receiving Systemic Treatment for Cancer: A Population-Based Cohort Study.
Journal: Journal of the National Cancer Institute
Published: January 15, 2018
Influence of control group therapy on the benefit from dose-dense chemotherapy in early breast cancer: a systemic review and meta-analysis.
Journal: Breast cancer research and treatment
Published: December 14, 2017
Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer: a systematic review.
Journal: Breast cancer research and treatment
Published: October 17, 2016
Last Updated: 09/26/2026